A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemiaSaroj Vadhan‐Raj, Eric Roeland, Jonathan W. Goldman et al.|Journal of Hematology & Oncology|2017Cited by 88